中药板块1月9日涨0.63%，维康药业领涨，主力资金净流出9572.45万元

Market Performance - The Chinese medicine sector rose by 0.63% on January 9, with Weikang Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 4120.43, up 0.92%, while the Shenzhen Component Index closed at 14120.15, up 1.15% [1] Top Gainers in Chinese Medicine Sector - Weikang Pharmaceutical (300878) closed at 35.33, with a significant increase of 20.01% and a trading volume of 68,800 shares, amounting to a transaction value of 231 million yuan [1] - Wanbangde (002082) saw a rise of 4.66%, closing at 15.05 with a trading volume of 195,600 shares [1] - Wohua Pharmaceutical (002107) increased by 3.23%, closing at 7.36 with a trading volume of 282,400 shares [1] Top Losers in Chinese Medicine Sector - ST Changyao (300391) experienced a decline of 6.90%, closing at 0.81 with a trading volume of 632,400 shares [2] - Enwei Pharmaceutical (301331) fell by 0.72%, closing at 28.85 with a trading volume of 18,300 shares [2] - Jiangzhong Pharmaceutical (600750) decreased by 0.65%, closing at 22.95 with a trading volume of 72,700 shares [2] Capital Flow Analysis - The Chinese medicine sector saw a net outflow of 95.72 million yuan from institutional investors, while retail investors contributed a net inflow of 171 million yuan [2] - Major stocks like Zhongsheng Pharmaceutical (002317) had a net inflow of 71.99 million yuan from institutional investors, despite a net outflow from retail investors [3] - Yunnan Baiyao (000538) also saw significant institutional inflow of 63.84 million yuan, while retail investors showed a net outflow [3]